[What is reliable in the therapy of cryptococcal meningitis?].
Glück
T
T
Abteilung Innere Medizin I (Gastroenterologie), Medizinischen Universitätsklinik Tübingen.
Weber
P
P
Dölle
W
W
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D016919:Meningitis, Cryptococcal / Q000188:drug therapy* / Q000382:microbiology; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000382:microbiology
D000935:Antifungal Agents
Was ist gesichert in der Therapie der Kryptokokkenmeningitis?